<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04641650</url>
  </required_header>
  <id_info>
    <org_study_id>FSL DIAL</org_study_id>
    <nct_id>NCT04641650</nct_id>
  </id_info>
  <brief_title>Pilot Study : FreeStyle Libre Pro Flash Continuous Glucose Monitoring System in Subjects With Diabetes on HemoDIALsis</brief_title>
  <acronym>FSL DIAL</acronym>
  <official_title>FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System in Subjects With Diabetes on HemoDIALsis (FSL-DIAL Pilot Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Saint Joseph Saint Luc de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Saint Joseph Saint Luc de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Continuous monitoring of glucose with a FreeStyle Libre pro sensor in diabetic and dialysis&#xD;
      patients&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 12, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference between estimated Hba1c (or Glucose Management Index (GMI)) with FreeStyle Libre Pro sensor and laboratory Hba1c</measure>
    <time_frame>At sensor removal (day 14)</time_frame>
    <description>Comparison between estimated HbA1c with 14 days of CGM data and laboratory HbA1c (routine blood test in hemodialysis) in each subject</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time in glucose range</measure>
    <time_frame>At sensor removal (day 14)</time_frame>
    <description>Percent (%) time in glucose range of ≥70 to ≤180 mg/dL (≥3.9 to ≤10 mmol/L), obtained using professional continuous glucose monitoring (CGM)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time with Glucose &lt; 70mg/dL</measure>
    <time_frame>At sensor removal (day 14)</time_frame>
    <description>% time with glucose &lt;70 mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time with Glucose &gt; 180 mg/dL</measure>
    <time_frame>At sensor removal (day 14)</time_frame>
    <description>% time with glucose &gt;180 mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose total coefficient of variation (CV)</measure>
    <time_frame>At sensor removal (day 14)</time_frame>
    <description>Glucose total CV (%)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Kidney Failure</condition>
  <condition>Diabetes</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with diabetes on hemodialysis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diabetes without any change in treatment in the last 3 months&#xD;
&#xD;
          -  Hemodialysis for &gt; 3 months&#xD;
&#xD;
          -  Recent laboratory HbA1c (&lt; 15 days)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient does not show non-opposition&#xD;
&#xD;
          -  Skin allergy to the sensor&#xD;
&#xD;
          -  Sepsis / Acute anaemia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lucien Marchand, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Study Principal Investigator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fanny Doroszewski</last_name>
    <phone>00330478618398</phone>
    <email>fdoroszewski@chsjsl.fr</email>
  </overall_contact>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 18, 2020</study_first_submitted>
  <study_first_submitted_qc>November 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2020</study_first_posted>
  <last_update_submitted>March 30, 2021</last_update_submitted>
  <last_update_submitted_qc>March 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glycemia</keyword>
  <keyword>diabetes</keyword>
  <keyword>kidney failure</keyword>
  <keyword>dialysis</keyword>
  <keyword>glucose sensor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

